A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2146162
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine the recommended Phase II dose of nilotinib when used in combination with cetuximab in the treatment of patients with recurrent and/or metastatic Kras wildtype colorectal cancer or squamous cell carcinoma of the head and neck.
创建时间：
2014-05-15
